methotrexate (MTX) and rheumatic disease Archives

Abstract Number: 2267 • ACR/ARHP Annual Meeting 2016
AMP-Activated Protein Kinase: A Target for Methotrexate in Macrophages
Cornelia Cudrici¹, Martin Pelletier² and Richard M. Siegel³, ¹NIAMS, Immunoregulation Section, Autoimmunity Branch, Bethesda, MD, ²Infectious and immune diseases Centre Hospitalier de l'Université Laval (CHUL) Québec, Québec, QC, Canada, ³National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD
Background/Purpose: Methotrexate (MTX) remains a cornerstone of treatment in multiple forms of inflammatory arthritis, lupus and vasculitis. The anti-inflammatory effects of MTX are more likely…

Abstracts tagged "methotrexate (MTX) and rheumatic disease"